Skip to Content

ADC Therapeutics

ADCT

Buy $ADCT at eToro
Rank 3434
Country USA
Exchange NYSE
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address BIOPOLE, ROUTE DE LA CORNICHE 3B, EPALINGES, CH

ADC Therapeutics - Key figures

Market cap 679.77 Million
Revenue 80.42 Million
Profit -125,478,000
P/E Ratio No information
P/s Ratio 8.45
Buy $ADCT at eToro

ADC Therapeutics - Description

ADC Therapeutics SA, a biotechnology company focused on clinical stage oncology, develops Antibody Drug Conjugates (ADC) for patients suffering from hematologic malignancies and solid tumors.

The company is headquartered in Epalinges, Switzerland.